aluates Reports

$ 0.0

Automative

Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-27H11910

Global Alzheimer s Disease Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028

BUY CHAPTERS

Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-27H11910

Report

June 2025

Pages:130

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Daiichi Sankyo

Merz Pharma

Pfizer Inc

Johnson & Johnson

Lundbeck

Allergan plc

Novartis

Eisai Co Ltd

Alzheimer's Disease Drug Market Size

In 2024, the global market size of Alzheimer's Disease Drug was estimated to be worth US$ 3727 million and is forecast to reach approximately US$ 4130 million by 2031 with a CAGR of 1.5% during the forecast period 2025-2031.

Alzheimer's Disease Drug Market

Alzheimer"s disease (AD), also referred to simply as Alzheimer"s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.

The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Alzheimer's Disease Drug Market Report

Report Metric	Details
Report Name	Alzheimer's Disease Drug Market
CAGR	1.5%
Segment by Type	Donepezil Memantine Rivastigmine Others
Segment by Application	Early to Moderate Stages Moderate to Severe Stages
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Alzheimer's Disease Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimer's Disease Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Alzheimer's Disease Drug Market?

Ans: The top 3 players hold over 60% of global shares.

What is the Alzheimer's Disease Drug Market share by type?

Ans: Memantine and Donepezil are the main types, with a share about 70%.

What is the Alzheimer's Disease Drug Market share by application?

Ans: Early to Moderate Stages is the key application, which covers over 55% shares.

Who are the main players in the Alzheimer's Disease Drug Market report?

Ans: The main players in the Alzheimer's Disease Drug Market are Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck

What are the Application segmentation covered in the Alzheimer's Disease Drug Market report?

Ans: The Applications covered in the Alzheimer's Disease Drug Market report are Early to Moderate Stages, Moderate to Severe Stages

What are the Type segmentation covered in the Alzheimer's Disease Drug Market report?

Ans: The Types covered in the Alzheimer's Disease Drug Market report are Donepezil, Memantine, Rivastigmine, Others

Recommended Reports

Alzheimer's Diagnostics & Treatment

Neurodegenerative & Cognitive

Broader CNS & Related Disorders

1 Study Coverage

1.1 Alzheimer's Disease Drug Product Introduction

1.2 Market by Type

1.2.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Donepezil

1.2.3 Memantine

1.2.4 Rivastigmine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Early to Moderate Stages

1.3.3 Moderate to Severe Stages

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts

2.1.1 Global Alzheimer's Disease Drug Revenue 2020-2031

2.1.2 Global Alzheimer's Disease Drug Sales 2020-2031

2.2 Alzheimer's Disease Drug Market Size by Region: 2024 Versus 2031

2.3 Alzheimer's Disease Drug Sales by Region (2020-2031)

2.3.1 Global Alzheimer's Disease Drug Sales by Region: 2020-2025

2.3.2 Global Alzheimer's Disease Drug Sales Forecast by Region (2026-2031)

2.3.3 Global Alzheimer's Disease Drug Sales Market Share by Region (2020-2031)

2.4 Alzheimer's Disease Drug Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Alzheimer's Disease Drug Revenue by Region: 2020-2025

2.4.2 Global Alzheimer's Disease Drug Revenue Forecast by Region (2026-2031)

2.4.3 Global Alzheimer's Disease Drug Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Alzheimer's Disease Drug Sales by Type (2020-2031)

3.1.1.1 Global Alzheimer's Disease Drug Sales Volume by Type (2020-2031)

3.1.1.2 Global Alzheimer's Disease Drug Sales Market Share by Type (2020-2031)

3.1.2 Global Alzheimer's Disease Drug Revenue by Type (2020-2031)

3.1.2.1 Global Alzheimer's Disease Drug Revenue by Type (2020-2031)

3.1.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Type (2020-2031)

3.1.3 Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Alzheimer's Disease Drug Sales by Application (2020-2031)

3.2.1.1 Global Alzheimer's Disease Drug Sales Volume by Application (2020-2031)

3.2.1.2 Global Alzheimer's Disease Drug Sales Market Share by Application (2020-2031)

3.2.2 Global Alzheimer's Disease Drug Revenue by Application (2020-2031)

3.2.2.1 Global Alzheimer's Disease Drug Revenue by Application (2020-2031)

3.2.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Application (2020-2031)

3.2.3 Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Donepezil of Alzheimer's Disease Drug Revenue Market Share by Application

3.3.2 Memantine of Alzheimer's Disease Drug Revenue Market Share by Application

3.3.3 Rivastigmine of Alzheimer's Disease Drug Revenue Market Share by Application

3.3.4 Others of Alzheimer's Disease Drug Revenue Market Share by Application

4 Global Alzheimer's Disease Drug by Manufacturers

4.1 Global Top Alzheimer's Disease Drug Manufacturers by Sales (2020-2025)

4.1.1 Global Alzheimer's Disease Drug Sales by Manufacturer (2020-2025)

4.1.2 Global Alzheimer's Disease Drug Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Alzheimer's Disease Drug Manufacturers by Revenue (2020-2025)

4.2.1 Global Alzheimer's Disease Drug Revenue by Manufacturer (2020-2025)

4.2.2 Global Alzheimer's Disease Drug Revenue Share by Manufacturer (2020-2025)

4.3 Global Alzheimer's Disease Drug Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Alzheimer's Disease Drug Manufacturers Covered: Ranking by Revenue

4.4.2 Global Alzheimer's Disease Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Alzheimer's Disease Drug Manufacturing Base Distribution, Product Type

4.5.1 Alzheimer's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Alzheimer's Disease Drug Market

4.5.3 Manufacturers Alzheimer's Disease Drug Product Type and Application

4.5.4 Donepezil Market Sales of Alzheimer's Disease Drug by Manufacturer

4.5.5 Memantine Market Sales of Alzheimer's Disease Drug by Manufacturer

4.5.6 Rivastigmine Market Sales of Alzheimer's Disease Drug by Manufacturer

4.5.7 Others Market Sales of Alzheimer's Disease Drug by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Allergan

5.1.1 Allergan Company Information

5.1.2 Allergan Description, Business Overview

5.1.3 Allergan Alzheimer's Disease Drug Products Offered

5.1.4 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Allergan Alzheimer's Disease Drug Sales by Product in 2024

5.1.6 Allergan Alzheimer's Disease Drug Sales by Application in 2024

5.1.7 Allergan Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.1.8 Allergan Recent Developments

5.2 Eisai

5.2.1 Eisai Company Information

5.2.2 Eisai Description, Business Overview

5.2.3 Eisai Alzheimer's Disease Drug Products Offered

5.2.4 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Eisai Alzheimer's Disease Drug Sales by Product in 2024

5.2.6 Eisai Alzheimer's Disease Drug Sales by Application in 2024

5.2.7 Eisai Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.2.8 Eisai Recent Developments

5.3 Novartis

5.3.1 Novartis Company Information

5.3.2 Novartis Description, Business Overview

5.3.3 Novartis Alzheimer's Disease Drug Products Offered

5.3.4 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Novartis Alzheimer's Disease Drug Sales by Product in 2024

5.3.6 Novartis Alzheimer's Disease Drug Sales by Application in 2024

5.3.7 Novartis Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.3.8 Novartis Recent Developments

5.4 Daiichi Sankyo

5.4.1 Daiichi Sankyo Company Information

5.4.2 Daiichi Sankyo Description, Business Overview

5.4.3 Daiichi Sankyo Alzheimer's Disease Drug Products Offered

5.4.4 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Daiichi Sankyo Alzheimer's Disease Drug Sales by Product in 2024

5.4.6 Daiichi Sankyo Alzheimer's Disease Drug Sales by Application in 2024

5.4.7 Daiichi Sankyo Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.4.8 Daiichi Sankyo Recent Developments

5.5 Merz Pharma

5.5.1 Merz Pharma Company Information

5.5.2 Merz Pharma Description, Business Overview

5.5.3 Merz Pharma Alzheimer's Disease Drug Products Offered

5.5.4 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Merz Pharma Alzheimer's Disease Drug Sales by Product in 2024

5.5.6 Merz Pharma Alzheimer's Disease Drug Sales by Application in 2024

5.5.7 Merz Pharma Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.5.8 Merz Pharma Recent Developments

5.6 Pfizer

5.6.1 Pfizer Company Information

5.6.2 Pfizer Description, Business Overview

5.6.3 Pfizer Alzheimer's Disease Drug Products Offered

5.6.4 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Pfizer Alzheimer's Disease Drug Sales by Product in 2024

5.6.6 Pfizer Alzheimer's Disease Drug Sales by Application in 2024

5.6.7 Pfizer Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.6.8 Pfizer Recent Developments

5.7 Johnson & Johnson

5.7.1 Johnson & Johnson Company Information

5.7.2 Johnson & Johnson Description, Business Overview

5.7.3 Johnson & Johnson Alzheimer's Disease Drug Products Offered

5.7.4 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Johnson & Johnson Alzheimer's Disease Drug Sales by Product in 2024

5.7.6 Johnson & Johnson Alzheimer's Disease Drug Sales by Application in 2024

5.7.7 Johnson & Johnson Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.7.8 Johnson & Johnson Recent Developments

5.8 Lundbeck

5.8.1 Lundbeck Company Information

5.8.2 Lundbeck Description, Business Overview

5.8.3 Lundbeck Alzheimer's Disease Drug Products Offered

5.8.4 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2020-2025)

5.8.5 Lundbeck Alzheimer's Disease Drug Sales by Product in 2024

5.8.6 Lundbeck Alzheimer's Disease Drug Sales by Application in 2024

5.8.7 Lundbeck Alzheimer's Disease Drug Sales by Geographic Area in 2024

5.8.8 Lundbeck Recent Developments

6 North America

6.1 North America Alzheimer's Disease Drug Market Size YoY Growth 2020-2031

6.2 North America Alzheimer's Disease Drug Market Facts & Figures by Country

6.2.1 North America Alzheimer's Disease Drug Sales by Country (2020-2031)

6.2.2 North America Alzheimer's Disease Drug Revenue by Country (2020-2031)

6.3 North America Alzheimer's Disease Drug Sales by Type (2020-2025)

6.4 North America Alzheimer's Disease Drug Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Alzheimer's Disease Drug Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Alzheimer's Disease Drug Market Facts & Figures by Region

7.2.1 Asia-Pacific Alzheimer's Disease Drug Sales by Region (2020-2031)

7.2.2 Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2020-2031)

7.3 Asia-Pacific Alzheimer's Disease Drug Sales by Type (2020-2025)

7.4 Asia-Pacific Alzheimer's Disease Drug Sales by Application (2020-2025)

8 Europe

8.1 Europe Alzheimer's Disease Drug Market Size YoY Growth 2020-2031

8.2 Europe Alzheimer's Disease Drug Market Facts & Figures by Country

8.2.1 Europe Alzheimer's Disease Drug Sales by Country (2020-2031)

8.2.2 Europe Alzheimer's Disease Drug Revenue by Country (2020-2031)

8.3 Europe Alzheimer's Disease Drug Sales by Type (2020-2025)

8.4 Europe Alzheimer's Disease Drug Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Alzheimer's Disease Drug Market Size YoY Growth 2020-2031

9.2 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country

9.2.1 Latin America Alzheimer's Disease Drug Sales by Country (2020-2031)

9.2.2 Latin America Alzheimer's Disease Drug Revenue by Country (2020-2031)

9.3 Latin America Alzheimer's Disease Drug Sales by Type (2020-2025)

9.4 Latin America Alzheimer's Disease Drug Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Alzheimer's Disease Drug Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country

10.2.1 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2020-2031)

10.2.2 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2020-2031)

10.3 Middle East and Africa Alzheimer's Disease Drug Sales by Type (2020-2025)

10.4 Middle East and Africa Alzheimer's Disease Drug Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Alzheimer's Disease Drug Supply Chain Analysis

11.2 Alzheimer's Disease Drug Key Raw Materials and Upstream Suppliers

11.3 Alzheimer's Disease Drug Clients Analysis

11.4 Alzheimer's Disease Drug Sales Channel and Sales Model Analysis

11.4.1 Alzheimer's Disease Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Alzheimer's Disease Drug Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Alzheimer's Disease Drug Distributors

12 Alzheimer's Disease Drug Market Dynamics

12.1 Alzheimer's Disease Drug Industry Trends

12.2 Alzheimer's Disease Drug Market Drivers

12.3 Alzheimer's Disease Drug Market Challenges

12.4 Alzheimer's Disease Drug Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Daiichi Sankyo

Merz Pharma

Pfizer Inc

Johnson & Johnson

Lundbeck

Allergan plc

Novartis

Eisai Co Ltd

List of Tables

Table 1. Global Alzheimer's Disease Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Alzheimer's Disease Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Alzheimer's Disease Drug Sales by Region (2020-2025) & (K Units)

Table 5. Global Alzheimer's Disease Drug Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Alzheimer's Disease Drug Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Alzheimer's Disease Drug Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Alzheimer's Disease Drug Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Alzheimer's Disease Drug Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Alzheimer's Disease Drug Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Alzheimer's Disease Drug Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Alzheimer's Disease Drug Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Alzheimer's Disease Drug Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Alzheimer's Disease Drug Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Alzheimer's Disease Drug Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Alzheimer's Disease Drug Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Alzheimer's Disease Drug Sales Share by Manufacturer (2020-2025)

Table 18. Alzheimer's Disease Drug Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Alzheimer's Disease Drug Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Alzheimer's Disease Drug Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Alzheimer's Disease Drug Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2024)

Table 24. Alzheimer's Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Alzheimer's Disease Drug Market

Table 26. Manufacturers Alzheimer's Disease Drug Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Allergan Company Information

Table 29. Allergan Description and Business Overview

Table 30. Allergan Alzheimer's Disease Drug Product

Table 31. Allergan Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Allergan Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 33. Allergan Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 34. Allergan Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 35. Allergan Recent Developments

Table 36. Eisai Company Information

Table 37. Eisai Description and Business Overview

Table 38. Eisai Alzheimer's Disease Drug Product

Table 39. Eisai Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. Eisai Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 41. Eisai Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 42. Eisai Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 43. Eisai Recent Developments

Table 44. Novartis Company Information

Table 45. Novartis Description and Business Overview

Table 46. Novartis Alzheimer's Disease Drug Product

Table 47. Novartis Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Novartis Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 49. Novartis Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 50. Novartis Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 51. Novartis Recent Developments

Table 52. Daiichi Sankyo Company Information

Table 53. Daiichi Sankyo Description and Business Overview

Table 54. Daiichi Sankyo Alzheimer's Disease Drug Product

Table 55. Daiichi Sankyo Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Daiichi Sankyo Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 57. Daiichi Sankyo Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 58. Daiichi Sankyo Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 59. Daiichi Sankyo Recent Developments

Table 60. Merz Pharma Company Information

Table 61. Merz Pharma Description and Business Overview

Table 62. Merz Pharma Alzheimer's Disease Drug Product

Table 63. Merz Pharma Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Merz Pharma Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 65. Merz Pharma Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 66. Merz Pharma Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 67. Merz Pharma Recent Developments

Table 68. Pfizer Company Information

Table 69. Pfizer Description and Business Overview

Table 70. Pfizer Alzheimer's Disease Drug Product

Table 71. Pfizer Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. Pfizer Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 73. Pfizer Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 74. Pfizer Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 75. Pfizer Recent Developments

Table 76. Johnson & Johnson Company Information

Table 77. Johnson & Johnson Description and Business Overview

Table 78. Johnson & Johnson Alzheimer's Disease Drug Product

Table 79. Johnson & Johnson Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Johnson & Johnson Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 81. Johnson & Johnson Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 82. Johnson & Johnson Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 83. Johnson & Johnson Recent Developments

Table 84. Lundbeck Company Information

Table 85. Lundbeck Description and Business Overview

Table 86. Lundbeck Alzheimer's Disease Drug Product

Table 87. Lundbeck Alzheimer's Disease Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Lundbeck Sales Proportion of Alzheimer's Disease Drug by Product in 2024

Table 89. Lundbeck Sales Proportion of Alzheimer's Disease Drug by Application in 2024

Table 90. Lundbeck Sales Proportion of Alzheimer's Disease Drug by Geographic Area in 2024

Table 91. Lundbeck Recent Developments

Table 92. North America Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)

Table 93. North America Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)

Table 94. North America Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)

Table 95. North America Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)

Table 96. North America Alzheimer's Disease Drug Sales by Type (2020-2025) & (K Units)

Table 97. North America Alzheimer's Disease Drug Sales by Application (2020-2025) & (K Units)

Table 98. Asia-Pacific Alzheimer's Disease Drug Sales by Region (2020-2025) & (K Units)

Table 99. Asia-Pacific Alzheimer's Disease Drug Sales by Region (2026-2031) & (K Units)

Table 100. Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2020-2025) & (US$ Million)

Table 101. Asia-Pacific Alzheimer's Disease Drug Revenue by Region (2026-2031) & (US$ Million)

Table 102. Asia-Pacific Alzheimer's Disease Drug Sales by Type (2020-2025) & (K Units)

Table 103. Asia-Pacific Alzheimer's Disease Drug Sales by Application (2020-2025) & (K Units)

Table 104. Europe Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)

Table 105. Europe Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)

Table 106. Europe Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)

Table 107. Europe Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)

Table 108. Europe Alzheimer's Disease Drug Sales by Type (2020-2025) & (K Units)

Table 109. Europe Alzheimer's Disease Drug Sales by Application (2020-2025) & (K Units)

Table 110. Latin America Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)

Table 111. Latin America Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)

Table 112. Latin America Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)

Table 113. Latin America Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)

Table 114. Latin America Alzheimer's Disease Drug Sales by Type (2020-2025) & (K Units)

Table 115. Latin America Alzheimer's Disease Drug Sales by Application (2020-2025) & (K Units)

Table 116. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2020-2025) & (K Units)

Table 117. Middle East and Africa Alzheimer's Disease Drug Sales by Country (2026-2031) & (K Units)

Table 118. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2020-2025) & (US$ Million)

Table 119. Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2026-2031) & (US$ Million)

Table 120. Middle East and Africa Alzheimer's Disease Drug Sales by Type (2020-2025) & (K Units)

Table 121. Middle East and Africa Alzheimer's Disease Drug Sales by Application (2020-2025) & (K Units)

Table 122. Alzheimer's Disease Drug Key Raw Materials, Industry Status and Trend

Table 123. Alzheimer's Disease Drug Key Raw Materials and Upstream Suppliers

Table 124. Alzheimer's Disease Drug Clients Status and Trend

Table 125. Alzheimer's Disease Drug Typical Clients

Table 126. Alzheimer's Disease Drug Distributors

Table 127. Alzheimer's Disease Drug Market Trends

Table 128. Alzheimer's Disease Drug Market Drivers

Table 129. Alzheimer's Disease Drug Market Challenges

Table 130. Alzheimer's Disease Drug Market Restraints

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Alzheimer's Disease Drug Product Picture

Figure 2. Global Alzheimer's Disease Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Alzheimer's Disease Drug Sales Market Share by Type in 2024 & 2031

Figure 4. Donepezil Product Picture

Figure 5. Memantine Product Picture

Figure 6. Rivastigmine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Alzheimer's Disease Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Alzheimer's Disease Drug Sales Market Share by Application in 2024 & 2031

Figure 10. Early to Moderate Stages

Figure 11. Moderate to Severe Stages

Figure 12. Alzheimer's Disease Drug Report Years Considered

Figure 13. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Alzheimer's Disease Drug Market Size 2020-2031 (US$ Million)

Figure 15. Global Alzheimer's Disease Drug Sales 2020-2031 (K Units)

Figure 16. Global Alzheimer's Disease Drug Sales Market Share Forecast by Region (2020-2031)

Figure 17. Global Alzheimer's Disease Drug Revenue Market Share by Region (2020-2031)

Figure 18. Global Alzheimer's Disease Drug Sales Market Share Forecast by Type (2020-2031)

Figure 19. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Type (2020-2031)

Figure 20. Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 21. Global Alzheimer's Disease Drug Sales Market Share Forecast by Application (2020-2031)

Figure 22. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Application (2020-2031)

Figure 23. Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 24. Donepezil of Alzheimer's Disease Drug Revenue Market Share by Application, 2024 VS 2031

Figure 25. Memantine of Alzheimer's Disease Drug Revenue Market Share by Application, 2024 VS 2031

Figure 26. Rivastigmine of Alzheimer's Disease Drug Revenue Market Share by Application, 2024 VS 2031

Figure 27. Others of Alzheimer's Disease Drug Revenue Market Share by Application, 2024 VS 2031

Figure 28. Global Alzheimer's Disease Drug Sales Share by Manufacturer in 2024

Figure 29. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 30. Donepezil Market Sales Proportion by Manufacturer in 2024

Figure 31. Memantine Market Sales Proportion by Manufacturer in 2024

Figure 32. Rivastigmine Market Sales Proportion by Manufacturer in 2024

Figure 33. Others Market Sales Proportion by Manufacturer in 2024

Figure 34. North America Alzheimer's Disease Drug Revenue 2020-2031 (US$ Million)

Figure 35. North America Alzheimer's Disease Drug Sales Market Share by Type (2020-2025)

Figure 36. North America Alzheimer's Disease Drug Sales Market Share by Application (2020-2025)

Figure 37. Asia-Pacific Alzheimer's Disease Drug Revenue 2020-2031 (US$ Million)

Figure 38. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Region (2020-2031)

Figure 39. Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Region (2020-2031)

Figure 40. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Type (2020-2025)

Figure 41. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Application (2020-2025)

Figure 42. Europe Alzheimer's Disease Drug Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Europe Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)

Figure 44. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2020-2031)

Figure 45. Europe Alzheimer's Disease Drug Sales Market Share by Type (2020-2025)

Figure 46. Europe Alzheimer's Disease Drug Sales Market Share by Application (2020-2025)

Figure 47. Latin America Alzheimer's Disease Drug Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Latin America Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)

Figure 49. Latin America Alzheimer's Disease Drug Revenue Market Share by Country (2020-2025)

Figure 50. Latin America Alzheimer's Disease Drug Sales Market Share by Type (2020-2025)

Figure 51. Latin America Alzheimer's Disease Drug Sales Market Share by Application (2020-2025)

Figure 52. Middle East and Africa Alzheimer's Disease Drug Revenue Growth Rate 2020-2031 (US$ Million)

Figure 53. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Type (2020-2025)

Figure 56. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Application (2020-2025)

Figure 57. Alzheimer's Disease Drug Supply Chain (Upstream and Downstream Market)

Figure 58. Global Production Market Share of Alzheimer's Disease Drug Raw Materials by Region in 2024

Figure 59. Alzheimer's Disease Drug Distribution Channels

Figure 60. Global Alzheimer's Disease Drug Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 61. Global Alzheimer's Disease Drug Percentage 2020-2031: Online Sales VS Offline Sales

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030

Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurodegenerative Disease Market Insights Forecast to 2030

Global Alzheimer s Disease Blood Test Kit Market Research Report 2024

Global Blood based Detection Kit for Early Diagnosis of Alzheimer s Disease Market Research Report 2024

Global Dementia Care Products Market Insights Forecast to 2030

Global Anti dementia Drugs Market Research Report 2024

Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Parkinson s Disease Treatment Market Insights Forecast to 2030

Global Targeted Drugs for Alzheimer s Disease Market Research Report 2024

Global Neurodegenerative Disease Treatment Market Research Report 2024

Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medications for Alzheimer s Disease Market Research Report 2024

Alzheimer s Disease Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medication for Dementia Symptoms Market Research Report 2024

Global Alzheimer s Drugs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions